CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Endo Pharmaceuticals Inc. v. Par Pharmaceutical Companies Inc.

1:14-cv-01385

Overview

Case Number 1:14-cv-01385
Filing Date 2014-11-07
Status Terminated
Termination Date 2015-03-31
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Inc. Operating Company

Represented By

2 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Par Pharmaceutical Companies Inc. Operating Company

Represented By

2 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Mallinckrodt LLC Operating Company

Represented By

2 Attorneys Listed

Julia Heaney

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Endo Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Julia Heaney

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8808737
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
Filed: 2010-03-03
Issued: 2014-08-19
Active (3.3 yrs remaining)
Expires: 2030-03-03
US8871779
Process for preparing morphinan-6-one products with low levels of Ξ±,Ξ²-unsaturated ketone compounds
Filed: 2007-03-02
Issued: 2014-10-28
Active (3.0 yrs remaining) +996d PTA
Expires: 2029-11-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

8

Dispositive

0

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Procedural / Extension Motion 8

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 14 Stipulation to Extend Time, filed by Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc. (Reset Answer Deadlines: Par Pharmaceutical Co...
Entry #β€” • 2015-03-11
Procedural / Extension Motion Pending / Under Review
STIPULATION to Extend Time to move, answer or otherwise respond to the Complaint to April 20, 2015, by Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc...
Entry #14 • 2015-03-10 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 13 STIPULATION TO EXTEND TIME to Respond to the Complaint to March 20, 2015, filed by Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc. ...
Entry #β€” • 2015-02-18
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Respond to the Complaint to March 20, 2015 - filed by Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc.. (Lester, Kathari...
Entry #13 • 2015-02-16 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 11 STIPULATION TO EXTEND TIME for Par to move, answer or otherwise respond to the Complaint to February 20, 2015, filed by Par Pharmaceutical Com...
Entry #β€” • 2015-01-08
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Par to move, answer or otherwise respond to the Complaint to February 20, 2015 - filed by Par Pharmaceutical Companies Inc., Par ...
Entry #11 • 2015-01-07 Document →

Docket Entries

(27 total)
Pleading / Complaint

COMPLAINT filed against All Defendants - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1622592.) - filed by Mallinckrodt LLC, Endo Phamaceuticals Inc.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(aah) (Entered: 11/10/2014)

Entry #1 • 2014-11-07
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 11/10/2014)

Entry #2 • 2014-11-07
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,808,737 B2; 8,871,779 B2; (aah) (Entered: 11/10/2014)

Entry #3 • 2014-11-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Endo Phamaceuticals Inc. filed by Endo Phamaceuticals Inc., Mallinckrodt LLC. (aah) (Entered: 11/10/2014)

Entry #4 • 2014-11-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc, Other Affiliate Mallinckrodt Inc. for Mallinckrodt LLC filed by Endo Phamaceuticals Inc., Mallinckrodt LLC. (aah) (Entered: 11/10/2014)

Entry #5 • 2014-11-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc